{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2025:ZLORXVRMKPWKHPNJ3MXI4T2X4X","short_pith_number":"pith:ZLORXVRM","canonical_record":{"source":{"id":"2503.22957","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-03-29T03:02:41Z","cross_cats_sorted":[],"title_canon_sha256":"acc5c66bc6f68414931b3a9f249b9d5a67d757adfc0c755a4576a8585bd09182","abstract_canon_sha256":"b2d4c179e73cea5e2dc4d43a12fe21d4cb2f7f817cfe16544a93889fa22c9fc2"},"schema_version":"1.0"},"canonical_sha256":"cadd1bd62c53eca3bda9db2e8e4f57e5da4b8b9806c377d0195b2a5ce8d29d49","source":{"kind":"arxiv","id":"2503.22957","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2503.22957","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"arxiv_version","alias_value":"2503.22957v1","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2503.22957","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"pith_short_12","alias_value":"ZLORXVRMKPWK","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"pith_short_16","alias_value":"ZLORXVRMKPWKHPNJ","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"pith_short_8","alias_value":"ZLORXVRM","created_at":"2026-07-05T10:41:28Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2025:ZLORXVRMKPWKHPNJ3MXI4T2X4X","target":"record","payload":{"canonical_record":{"source":{"id":"2503.22957","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-03-29T03:02:41Z","cross_cats_sorted":[],"title_canon_sha256":"acc5c66bc6f68414931b3a9f249b9d5a67d757adfc0c755a4576a8585bd09182","abstract_canon_sha256":"b2d4c179e73cea5e2dc4d43a12fe21d4cb2f7f817cfe16544a93889fa22c9fc2"},"schema_version":"1.0"},"canonical_sha256":"cadd1bd62c53eca3bda9db2e8e4f57e5da4b8b9806c377d0195b2a5ce8d29d49","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T10:41:28.190176Z","signature_b64":"2caEqyijoD7vdvOoTlHAIJxy6ZZ+G+k8UwsmvHoGYOe4NZkKEv3mR8S8/OKvqxtDaxEJN1j8l52ohQLh1IepBg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"cadd1bd62c53eca3bda9db2e8e4f57e5da4b8b9806c377d0195b2a5ce8d29d49","last_reissued_at":"2026-07-05T10:41:28.189716Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T10:41:28.189716Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2503.22957","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T10:41:28Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"lJsJeNbQQ+UBh1GIk3/hev7Zr3yuSjOaAi/wP1FwGbRqMiwoYZMdjcedw/EHNqKeC1zD65w6KslFQv0o9ogpDg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-08T20:57:08.632027Z"},"content_sha256":"b57afe294541febc575f3e461d910171d2ed241e8124588112b9875cfda0f701","schema_version":"1.0","event_id":"sha256:b57afe294541febc575f3e461d910171d2ed241e8124588112b9875cfda0f701"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2025:ZLORXVRMKPWKHPNJ3MXI4T2X4X","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Eunhee Kim, Hao Sun, Jieqi Tu, Revathi Ananthakrishnan","submitted_at":"2025-03-29T03:02:41Z","abstract_excerpt":"Oncology dose-finding trials are shifting from identifying the maximum tolerated dose (MTD) to determining the optimal biological dose (OBD), driven by the need for efficient methods that consider both toxicity and efficacy. This is particularly important for novel therapies, such as immunotherapies and molecularly targeted therapies, which often exhibit non-monotonic dose-efficacy curves. However, making timely adaptive dosing decisions is challenging due to the rapid patient accrual rate and the late-onset toxicity and/or efficacy outcomes associated with these therapies. The Simple Toxicity"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2503.22957","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2503.22957/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T10:41:28Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"cTbnOs6vmexAfRqhSAdEj9tvNiSxhYm9dEc09CuMfBBB0QQR8yH0V0TnkcByDGLJ3MMf4MreauZWc1WuTQbkBg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-08T20:57:08.632583Z"},"content_sha256":"1c332cfdadb80094c8c7a0b6bb2b1c323d5bc42079989ab6233b4049611c92a8","schema_version":"1.0","event_id":"sha256:1c332cfdadb80094c8c7a0b6bb2b1c323d5bc42079989ab6233b4049611c92a8"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/ZLORXVRMKPWKHPNJ3MXI4T2X4X/bundle.json","state_url":"https://pith.science/pith/ZLORXVRMKPWKHPNJ3MXI4T2X4X/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/ZLORXVRMKPWKHPNJ3MXI4T2X4X/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-08T20:57:08Z","links":{"resolver":"https://pith.science/pith/ZLORXVRMKPWKHPNJ3MXI4T2X4X","bundle":"https://pith.science/pith/ZLORXVRMKPWKHPNJ3MXI4T2X4X/bundle.json","state":"https://pith.science/pith/ZLORXVRMKPWKHPNJ3MXI4T2X4X/state.json","well_known_bundle":"https://pith.science/.well-known/pith/ZLORXVRMKPWKHPNJ3MXI4T2X4X/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2025:ZLORXVRMKPWKHPNJ3MXI4T2X4X","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"b2d4c179e73cea5e2dc4d43a12fe21d4cb2f7f817cfe16544a93889fa22c9fc2","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-03-29T03:02:41Z","title_canon_sha256":"acc5c66bc6f68414931b3a9f249b9d5a67d757adfc0c755a4576a8585bd09182"},"schema_version":"1.0","source":{"id":"2503.22957","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2503.22957","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"arxiv_version","alias_value":"2503.22957v1","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2503.22957","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"pith_short_12","alias_value":"ZLORXVRMKPWK","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"pith_short_16","alias_value":"ZLORXVRMKPWKHPNJ","created_at":"2026-07-05T10:41:28Z"},{"alias_kind":"pith_short_8","alias_value":"ZLORXVRM","created_at":"2026-07-05T10:41:28Z"}],"graph_snapshots":[{"event_id":"sha256:1c332cfdadb80094c8c7a0b6bb2b1c323d5bc42079989ab6233b4049611c92a8","target":"graph","created_at":"2026-07-05T10:41:28Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2503.22957/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Oncology dose-finding trials are shifting from identifying the maximum tolerated dose (MTD) to determining the optimal biological dose (OBD), driven by the need for efficient methods that consider both toxicity and efficacy. This is particularly important for novel therapies, such as immunotherapies and molecularly targeted therapies, which often exhibit non-monotonic dose-efficacy curves. However, making timely adaptive dosing decisions is challenging due to the rapid patient accrual rate and the late-onset toxicity and/or efficacy outcomes associated with these therapies. The Simple Toxicity","authors_text":"Eunhee Kim, Hao Sun, Jieqi Tu, Revathi Ananthakrishnan","cross_cats":[],"headline":"","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-03-29T03:02:41Z","title":"TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2503.22957","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:b57afe294541febc575f3e461d910171d2ed241e8124588112b9875cfda0f701","target":"record","created_at":"2026-07-05T10:41:28Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"b2d4c179e73cea5e2dc4d43a12fe21d4cb2f7f817cfe16544a93889fa22c9fc2","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-03-29T03:02:41Z","title_canon_sha256":"acc5c66bc6f68414931b3a9f249b9d5a67d757adfc0c755a4576a8585bd09182"},"schema_version":"1.0","source":{"id":"2503.22957","kind":"arxiv","version":1}},"canonical_sha256":"cadd1bd62c53eca3bda9db2e8e4f57e5da4b8b9806c377d0195b2a5ce8d29d49","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"cadd1bd62c53eca3bda9db2e8e4f57e5da4b8b9806c377d0195b2a5ce8d29d49","first_computed_at":"2026-07-05T10:41:28.189716Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T10:41:28.189716Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"2caEqyijoD7vdvOoTlHAIJxy6ZZ+G+k8UwsmvHoGYOe4NZkKEv3mR8S8/OKvqxtDaxEJN1j8l52ohQLh1IepBg==","signature_status":"signed_v1","signed_at":"2026-07-05T10:41:28.190176Z","signed_message":"canonical_sha256_bytes"},"source_id":"2503.22957","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:b57afe294541febc575f3e461d910171d2ed241e8124588112b9875cfda0f701","sha256:1c332cfdadb80094c8c7a0b6bb2b1c323d5bc42079989ab6233b4049611c92a8"],"state_sha256":"e49874a768766706f25403109b4015c24435a0d579606dc5409ce1d11562357e"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"ccqNPumDSYX4unVmbj3tnIz4cyGXDYpxxSbN0hEAULW295l3HgBN7lFs3R26iBJ5nY8Zyi8NOfiF+CYDS5zMBw==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-08T20:57:08.636864Z","bundle_sha256":"62a1059e06b7d7a3cc37ae79fc0db26d6f98f5fba55a347edf825e42059b0221"}}